Skip to main content

Want a detailed portfolio tracker?

Brainstorm Cell Therapeutics (BCLI) Return on Assets (ROA) (2002 - 2026)

Brainstorm Cell Therapeutics (BCLI) Return on Assets (ROA) from Mar 31, 2002 to Mar 31, 2026. The TTM Brainstorm Cell Therapeutics (BCLI) Return on Assets (ROA) is -281.72%. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual ROA

Quarterly ROA

Annual Return on Assets (ROA) change of Brainstorm Cell Therapeutics (BCLI)

YearReturn on Assets (ROA)Change
2025-1010.78%
+59.19%
2024-634.97%
+55.51%
2023-408.31%
+42.10%
2022-287.34%
+243.96%
2021-83.54%
+34.62%
2020-62.06%
-82.57%
2019-356.05%
+186.63%
2018-124.22%
+186.59%
2017-43.35%
-6.26%
2016-46.24%
-6.98%
2015-49.71%
-46.75%
2014-93.34%
-9.90%
2013-103.59%
+55.24%
2012-66.73%
-53.36%
2011-143.07%
-35.56%
2010-222.02%
-100.00%
2009-Infinity%
N/A
2008-Infinity%
N/A
2007-Infinity%
N/A
2006-Infinity%
N/A
2004-Infinity%
N/A
2003-Infinity%
N/A
2002-Infinity%
N/A